Dermsquared - The leading solutions platform for dermatology professionals to elevate patient care

Biologics Innovation Experience

Learn & earn with Dermsquared Experiences

Video

The Itch Factor: Why Relief Can’t Wait in Atopic Dermatitis

Feat. Matthew Zirwas, MD, Raj Chovatiya, MD, PhD, MSCI

Podcast

Shedding New Light on Phototherapy: Now in the Comfort of Your Own Home

Feat. E. James Song, MD

Case Study

Jacked on JAKs: The Therapeutic Impact of Dose Escalation in a Case of Refractory Atopic Dermatitis

By Graham Litchman, DO, MS

CME

CMEswiper: Swipe to See CLE: Recognition and Diagnosis of Cutaneous Lupus Erythematosus: An Online Activity

With Victoria Werth, MD

Innovation Corner

Rethinking Psoriatic Disease

Treating psoriatic disease means paying attention to what’s visible on the skin and what may be unfolding beneath it. With the expansion of deucravacitinib into psoriatic arthritis, the question is no longer just which therapy improves plaques. It’s how we identify patients earlier, think about joint risk in a dermatology setting, and make decisions for patients who don’t quite fit our usual categories. Across the experience, faculty translate this into practice by exploring how often psoriatic arthritis is missed or delayed, which patients begin to stand out, where an oral TYK2 inhibitor may fit, and what remains unresolved in day-to-day care.

Innovation Corner

Rethinking Psoriatic Disease

Treating psoriatic disease means paying attention to what’s visible on the skin and what may be unfolding beneath it. With the expansion of deucravacitinib into psoriatic arthritis, the question is no longer just which therapy improves plaques. It’s how we identify patients earlier, think about joint risk in a dermatology setting, and make decisions for patients who don’t quite fit our usual categories. Across the experience, faculty translate this into practice by exploring how often psoriatic arthritis is missed or delayed, which patients begin to stand out, where an oral TYK2 inhibitor may fit, and what remains unresolved in day-to-day care.

Continue Your Learning Journey

Biologics Innovation Experience

Look beyond the exam itself, listen closely to the history, and reconsider CSU treatment.

Start Experience

PANP360º

A space for PAs and NPs to connect, learn, and bring the best dermatology education into daily care practice.

Visit PANP360º

Support Your Practice

Learn, share and grow your expertise in patient access and how to within dermatology practice management

Learn More

Continue Your CME Learning

Review your recently completed and in-progress CME activities and continue your learning journey.

Check Your Progress

Latest Expert Videos

How can dermatologists decide between lesion-directed and field-directed therapies when treating actinic keratosis?

The Axial Advantage: Expanding Psoriasis Care Across Indications

The Itch Factor: Why Relief Can’t Wait in Atopic Dermatitis

How can dermatologists improve diagnostic accuracy for AD in skin of color?

Latest Expert Videos

How can dermatologists decide between lesion-directed and field-directed therapies when treating actinic keratosis?

The Axial Advantage: Expanding Psoriasis Care Across Indications

The Itch Factor: Why Relief Can’t Wait in Atopic Dermatitis

How can dermatologists improve diagnostic accuracy for AD in skin of color?

Innovation Corner

Rethinking Psoriatic Disease

Treating psoriatic disease means paying attention to what’s visible on the skin and what may be unfolding beneath it. With the expansion of deucravacitinib into psoriatic arthritis, the question is no longer just which therapy improves plaques. It’s how we identify patients earlier, think about joint risk in a dermatology setting, and make decisions for patients who don’t quite fit our usual categories. Across the experience, faculty translate this into practice by exploring how often psoriatic arthritis is missed or delayed, which patients begin to stand out, where an oral TYK2 inhibitor may fit, and what remains unresolved in day-to-day care.

Upcoming Conferences

2026 PANP360 Boston

Aug 14, 2026 | Boston Marriott Copley Place, Boston, MA

2026 Masters of Aesthetics Symposium West

Aug 28, 2026 | San Diego, CA

2026 Fall Clinical Dermatology Conference

Oct 08, 2026 | Wynn Las Vegas, NV

Patient Access Management Summit (PAMS) – Orlando

Dec 05, 2026 | Orlando, FL

Total Impact Miami 2027

Jan 15, 2027 | Aventura, FL

Trending News

FDA expands ZORYVE (roflumilast) cream 0.3% indication to children as young as 2 years with plaque psoriasis

By Dermsquared Editorial Team | | July 02, 2026

In CSU, Hives Are Only the Beginning

By Dermsquared Editorial Team | | July 01, 2026

Poly-L-Lactic Acid Safe, Effective for Correction of Décolletage Wrinkles

By Dermsquared Editorial Team | | June 22, 2026

Extra Lesions ID'd During Mohs Visits Are Often Nonmelanoma Skin Cancer

By Dermsquared Editorial Team | | June 22, 2026

Melanoma Incidence and Deaths Disproportionately Impact Men

By Lori Solomon (HealthDay News) | | June 22, 2026

Oral Nicotinamide Cost-Effective for Preventing Keratinocyte Carcinoma

By Dermsquared Editorial Team | | June 22, 2026

Generally Mild, Managed Adverse Effects Seen With Combo Treatment for Hair Loss

By Dermsquared Editorial Team | | June 22, 2026

FDA Approves First New Sunscreen Ingredient in Two Decades

By Deanna Neff (HealthDay News) | | June 22, 2026

Dose Reduction of Biologics Effective, Safe for Psoriasis

By Meeta Shah, MD (HealthDay News) | | June 22, 2026

Culturally Sensitive Hair Loss Examination: A Framework for Advanced Practice Dermatology Providers

By KimberlyG. Baker, NP | | June 09, 2026